← All stocks

PepGen Inc.

PEPG Net buying
CIK 0001835597 #3887 in the set updated 17 Sep 2026
Bought (120 mo)
$101.73M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.72M
$0.00 on a plan · $1.52M straight out of an exercise
Sold at will
$198.38K
10 of 31 sales
Net
+$100.01M
+$101.53M against sales at will

By person

13 insiders · 44 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$95.96M (4)
+$95.96M
18,554,273
$26.17M
Flynn James E
10% owner
$5.00M (2)
+$5.00M
476,813
$672.64K
Mellion Michelle L
Chief Medical Officer
$905.69K (12) scheduled
−$905.69K
0
$0.00
Oxford Science Enterprises plc entity
Former 10% Owner
$640.00K (1)
+$640.00K
4,955,388
$6.99M
+396.1%
McArthur James G
President and CEO
$68.33K (3)
$538.23K (7) scheduled
−$469.90K
296,326
$418.03K
Svenstrup Niels
SVP, Chem. Mfg & Controls
$134.10K (1)
−$134.10K
0
$0.00
Goyal Jaya
EVP, Res. & Preclin. Dev.
$110.57K (4) scheduled
−$110.57K
0
$0.00
KEATING LAURIE
Director
$49.99K (1)
+$49.99K
4,166
$5.88K
Donnelly Noel
Chief Financial Officer
$15.55K (3)
−$15.55K
111,603
$157.44K
+834.9%
DeLena Mary Beth
General Counsel
$2.41K (1)
−$2.41K
14,968
$21.12K
Kasraian Kasra
Chief Technical Officer
$1.74K (1)
−$1.74K
50,074
$70.64K
STRECK PAUL
EVP, Head of R&D
$10.39K (1)
$11.71K (2)
−$1.32K
76,226
$107.53K
Vittiglio Joseph
Chief Business & Legal Officer
65,717
$92.71K

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 32,595,737 to 69,259,517 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mellion Michelle L
25 Jul 2024
Chief Medical Officer
Sold after exercise
7,571
$18.06
$136.74K
Mellion Michelle L
24 Jul 2024
Chief Medical Officer
Sold after exercise
201
$18.01
$3.62K
Mellion Michelle L
18 Jul 2024
Chief Medical Officer
Sold after exercise
12,625
$18.20
$229.80K
Mellion Michelle L
16 Jul 2024
Chief Medical Officer
Sold after exercise
5,901
$18.00
$106.25K
Mellion Michelle L
12 Jul 2024
Chief Medical Officer
Sold after exercise
3,288
$18.04
$59.33K
Mellion Michelle L
2 Jul 2024
Chief Medical Officer
Sold after exercise
37
$18.07
$668.59
Mellion Michelle L
1 Jul 2024
Chief Medical Officer
Sold after exercise
875
$18.01
$15.76K
Mellion Michelle L
24 Jun 2024
Chief Medical Officer
Sold after exercise
9,260
$18.19
$168.43K
Mellion Michelle L
12 Jun 2024
Chief Medical Officer
Sold after exercise
1,086
$18.06
$19.61K
Mellion Michelle L
11 Jun 2024
Chief Medical Officer
Sold after exercise
500
$18.04
$9.02K
Mellion Michelle L
6 Jun 2024
SVP, Clinical Development
Sold after exercise
1,411
$18.00
$25.40K
Mellion Michelle L
5 Jun 2024
SVP, Clinical Development
Sold after exercise
7,245
$18.09
$131.06K
McArthur James G
8 Jun 2023
President and CEO
Sold after exercise
2,381
$16.04
$38.19K
McArthur James G
7 Jun 2023
President and CEO
Sold after exercise
8,419
$16.23
$136.62K
McArthur James G
6 Jun 2023
President and CEO
Sold after exercise
18,150
$16.18
$293.66K
McArthur James G
5 Jun 2023
President and CEO
Sold after exercise
500
$16.06
$8.03K
McArthur James G
2 Jun 2023
President and CEO
Sold after exercise
1,800
$16.04
$28.86K
Goyal Jaya
24 Mar 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
392
$20.00
$7.84K
Goyal Jaya
8 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
644
$17.00
$10.95K
Goyal Jaya
7 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
3,679
$17.18
$63.21K
Goyal Jaya
6 Feb 2023
EVP, Res. & Preclin. Dev.
Sold after exercise
1,677
$17.04
$28.57K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 9,848,749
History held since 10 May 2022